ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
6,013.13
-1.71%
US Tech 100
21,134.00
0.43%
다우존스 지수
43,428.02
-1.69%
Bitcoin
95,691.30
-0.60%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Akari Therapeutics PLC (AKTX)

  7. Akari Therapeutics PLC (AKTX) 뉴스

AKTX

Akari Therapeutics (AKTX)

Akari Therapeutics PLC
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:AKTX
일자시간출처헤드라인심볼기업
2025/02/1923:00GlobeNewswire Inc.Akari Therapeutics Participates in the Virtual Investor “Top 5 for ‘25” On-Demand ConferenceNASDAQ:AKTXAkari Therapeutics PLC
2025/02/1507:00Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AKTXAkari Therapeutics PLC
2025/02/0806:30Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:AKTXAkari Therapeutics PLC
2025/02/0322:00GlobeNewswire Inc.Akari Therapeutics Joins Webull Corporate Connect Service PlatformNASDAQ:AKTXAkari Therapeutics PLC
2025/01/1322:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2025/01/1322:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2025/01/1322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKTXAkari Therapeutics PLC
2025/01/1107:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2025/01/0806:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/3106:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/3106:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/2806:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/2806:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/2706:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/2706:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/2706:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/2706:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/2106:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/1906:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKTXAkari Therapeutics PLC
2024/12/1822:51GlobeNewswire Inc.Akari Therapeutics Announces Key Leadership AppointmentsNASDAQ:AKTXAkari Therapeutics PLC
2024/12/1706:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AKTXAkari Therapeutics PLC
2024/12/1623:05GlobeNewswire Inc.Akari Therapeutics Appoints Torsten Hombeck, Ph.D. as Chief Financial OfficerNASDAQ:AKTXAkari Therapeutics PLC
2024/12/0706:00Edgar (US Regulatory)Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]NASDAQ:AKTXAkari Therapeutics PLC
2024/12/0407:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/12/0407:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/11/2306:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/11/2306:30Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/11/2006:48Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AKTXAkari Therapeutics PLC
2024/11/1910:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AKTXAkari Therapeutics PLC
2024/11/1606:05Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:AKTXAkari Therapeutics PLC
 검색 관련기사 보기:NASDAQ:AKTX

최근 히스토리

NYSE
JPM
JP Morgan Chase
FX
USDGBP
US Dollar vs Sterling
COIN
AVAXUSD
Avalanche
COIN
ETHUSD
Ethereum
COIN
BTCUSD
Bitcoin
NYSE
NKE
Nike
NYSE
BAC
Bank of America
AMEX
SPY
SPDR S&P 500
FX
USDJPY
US Dollar vs Yen
PM
XAUUSD
Gold vs US Dollar
NYSE
CVX
Chevron
NYSE
MRK
Merck
SPI
SP500
S&P 500
CCOM
SILVER
SILVER
NYSE
MCD
McDonalds
NASDAQ
MSFT
Microsoft
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

대한민국
회사 소개
사업
Popular
앱 받기
App Store
Google Play

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2025 ADVFN PLC - 모든 권리 보유

광고 제거

광고 없는 경험을 위해 가입하세요

광고 없음

지금 사용해 보세요

광고 유지